Chang Jin Wang
Oprichter bij FRONTIER BIOTECHNOLOGIES INC.
Vermogen: 19 M $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Rong Jian Lu | M | 62 | 11 jaar | |
| Dong Xie | M | 58 | 11 jaar | |
| Yu Ting Zhu | F | 35 | 10 jaar | |
| David Chung | M | - |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 21 jaar |
| Guang Ji Wang | M | 71 | 2 jaar | |
| Chi Kit Ng | M | 51 | 5 jaar | |
| Qian Ya Gao | F | 38 | 5 jaar | |
| Kai Chen | M | 65 | 5 jaar | |
| Xiao Hong Zheng | M | 62 | 5 jaar | |
| Kuo Lung Huang | M | - |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | 20 jaar |
| Li Na Bao | F | - | 8 jaar | |
| Yuan Tao Cao | M | 43 | 6 jaar | |
| Zhi Zhong Jiang | M | 42 | 10 jaar | |
| Qi Shao | M | 44 | 9 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Xian Wang | M | 57 | 3 jaar | |
| Isamu Oh | M | 56 | 5 jaar | |
| Shirley Liu Clayton | F | 86 |
Abmaxis, Inc.
 Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | 3 jaar |
| Bruce Keyt | M | 71 |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | 1 jaar |
| Hong Hai Wen | M | 59 | 6 jaar | |
| Yan Li | F | 50 |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| China | 15 | 75.00% |
| Verenigde Staten | 3 | 15.00% |
| Taiwan | 2 | 10.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Chang Jin Wang
- Persoonlijk netwerk
